Most advice for families of someone with bipolar disorder is about surviving mania. Most of what you are actually living with is the long flat stretch afterwards, the third month of a depression, and the slow question of how much of your own life you are allowed to keep.

The short answer: families are not bystanders in this illness — they are one of the better-evidenced parts of the treatment. In a randomised trial, adding family-focused therapy to medication reduced relapses and lengthened the time to relapse, with a hazard ratio of 0.38, and improved medication adherence over two years. In a synthesis of 39 trials, psychoeducation with guided skills practice delivered in a family or group format beat the same content delivered individually. And the specific job the evidence gives you is not managing someone's moods; it is being the other person who can see the pattern — because the corroborative history is the thing the diagnosis needs and the early warning signs are what prevent the next episode.¹ ² ³

What the research says families are for

A corroborative history. The assessment guideline asks clinicians to "encourage people to invite a family member or carer to give a corroborative history."⁴ Elevated mood is the symptom people are least able to report about themselves. If you have watched someone not sleep for four days and start three businesses, you hold information that no questionnaire will recover — and diagnostic delay in this illness runs to a median of about 6.7 years. Why it takes so long →

Early warning signs. This is the intervention with the strongest evidence type in the whole field: a Cochrane review of trials teaching people to recognise early signs of recurrence found time to first recurrence favoured the intervention, hazard ratio 0.57 (95% CI 0.39–0.82), and concluded that "Mental health services should consider routinely providing EWS interventions to adults with bipolar disorder."⁵ Families are usually the ones who notice first.

A treatment in your own right. In the primary family-focused therapy trial, 101 patients were randomised to 21 sessions over nine months of psychoeducation, communication training and problem-solving with the family — or to a lighter crisis-management condition. "Patients undergoing FFT had fewer relapses (11/31, 35%) and longer survival intervals… than patients undergoing CM (38/70, 54%…; hazard ratio, 0.38; 95% confidence interval, 0.20-0.75; P = .003)," and showed "greater reductions in mood disorder symptoms and better medication adherence during the 2 years."¹ In a separate trial after hospitalisation for mania, patients in family treatment "were less likely to be rehospitalized during the 2-year study period."⁶

And the format finding. Across 39 trials and 3,863 participants, psychoeducation with guided practice of illness-management skills "in a family or group format was associated with reducing recurrences vs the same strategies in an individual format (OR, 0.12; 95% CI, 0.02-0.94)."² One synthesis, wide interval — but it points the same way as the family trials.

The guideline turns this into a recommendation: "Offer a family intervention to people with bipolar disorder who are living, or in close contact, with their family."⁷

The relapse-prevention plan, which is the practical core

The guideline asks for a written risk-management plan developed jointly with the person and, where possible, their carer, covering: "identifiable personal, social, occupational, or environmental triggers and early warning signs and symptoms of relapse"; a protocol for applying coping strategies and — where agreed in advance with a prescriber — adjusting medication; agreements about how services respond to increased risk; and who to contact in a crisis. It asks that the person and their doctor each get a copy and that the person be encouraged to share it with carers.⁸

Build it when things are calm. The parts to fill in together:

  • The three earliest signs of a high. Not "he gets manic." Sleep dropping without tiredness. Talking faster. New projects. Spending. Irritability at small obstacles. Be embarrassingly specific.
  • The three earliest signs of a low. Withdrawing from one particular friend. Stopping a specific routine. The phone going unanswered.
  • What each of you does at sign one. Usually: call the prescriber, protect sleep, hold off on decisions. Agree it in advance so it is not a negotiation in the moment.
  • What is agreed in advance about money, driving and big decisions during an episode. The risk assessment guideline names "driving, spending money excessively, financial or sexual exploitation" as areas to plan around.⁹
  • Who to call, in order, with numbers. Including 988.
  • What you are not to do, agreed by the person while well — which is what makes it possible for you to do it later.

Between episodes, which is most of the time

The temptation is to organise your life around the crises. The data say that is the wrong place to put your attention.

People with bipolar I are symptomatic 47.3 percent of weeks, and 31.9 percent of all weeks are depressive; for bipolar II it is 53.9 percent symptomatic and 50.3 percent depressive.¹⁰ ¹¹ Most of that is subsyndromal — not an episode, not nothing. And it is where the disability lives: psychosocial impairment rises with each increment of depressive symptom severity, while subsyndromal hypomanic symptoms are not disabling.¹²

Which reframes the job. The dramatic weeks are not where most of the suffering is. The unglamorous, low, flat, ordinary weeks are.

Two specific things worth knowing about those weeks. Residual mood symptoms at the point of recovery were the strongest predictor of recurrence in the largest effectiveness study¹³ — so "mostly better" is worth taking to a prescriber rather than accepting with relief. And after a first hospitalisation for mania, 98 percent achieved syndromal recovery within two years but only 43 percent achieved functional recovery.¹⁴ Getting a life back is a slower, separate project from getting well, and it is one families can actually help with.

Medication, adherence, and the conversation to have differently

Roughly 44 percent of people with bipolar disorder are non-adherent to psychotropic medication in a pooled analysis; another review puts it at around 40 percent.¹⁵ ¹⁶ It is the single most common precipitant of relapse and one of the most common sources of conflict in a household.

Before treating it as a willpower problem, look at what the research says drives it. In the largest real-world study of why people stop lithium specifically, of 873 patients, 54 percent discontinued — and "in 62% of episodes, lithium was discontinued due to adverse effects," the commonest being diarrhoea, tremor, excessive urination and thirst, a rise in creatinine, and weight gain.¹⁷ A systematic review mapping the determinants found the most common domains were "environmental context and resources (e.g. experiencing side effects)" and "beliefs about consequences," followed by knowledge, social influences and forgetfulness.¹⁶

So the useful sentence is not "you need to take your medication." It is "which part of it is unbearable, and does your prescriber know?" Side effects are a clinical problem with clinical solutions. Framing them as a character failing guarantees they stay hidden.

And one thing to know rather than to enforce: after stopping stable lithium maintenance, more than half of new episodes occurred within ten weeks, and the risk of early recurrence — especially of mania — exceeded what the untreated course would predict.¹⁸ Rapid discontinuation is a specific hazard. That is information to bring to a prescriber, not an argument to win at the kitchen table.

The part nobody tells families

Most of the excess mortality in bipolar disorder is not suicide. All-cause mortality is roughly doubled; women and men with the diagnosis died 9.0 and 8.5 years earlier than the rest of the population in a national cohort. The suicide standardised mortality ratio is high — around 14 — but applies to a small denominator; the natural-cause ratio of about 1.6 applies to a very large one, and in a 23-year hospital cohort "for bipolar disorder, most excess deaths were from natural causes."¹⁹ ²⁰ ²¹

And there is a finding that reads like a task list. The link between bipolar disorder and death from chronic physical disease was weaker among people who already had a diagnosis of that physical condition — which the authors read as "suggesting that better provision of primary medical care may effectively reduce premature mortality among persons with bipolar disorder."²⁰

Nagging someone to a primary care appointment, a blood pressure check, a cholesterol test, a conversation about smoking, is not a distraction from the mental illness. On this evidence it may be one of the more consequential things a family does.

Looking after your own side of it

  • Get your own support. Family programmes exist for exactly this. NAMI Family-to-Family is a free, eight-session course taught by trained family members and available through California affiliates; its randomised trial in 318 family members found "significantly greater improvements in problem-focused coping as measured by empowerment and illness knowledge," with reduced distress — though "Subjective illness burden did not differ between groups," and the trials studied a longer version of the course than the one now offered, in relatives of people with mixed serious mental illness rather than bipolar disorder specifically.²²
  • Ask to be included in the plan, formally. The guideline asks for carers to be part of crisis planning and for plans to be reviewed with families after a crisis.⁸ You are allowed to ask for this in writing.
  • Keep your own life running. The evidence on family involvement is about structured, bounded work — 21 sessions, a plan, specific skills — not about becoming a full-time monitor.
  • Separate the illness from the person, out loud, when well. Agree in advance what you will say during an episode and what you will both ignore afterwards.
  • Get a therapist of your own if the years have accumulated. Find one → · The caregivers page →

Q&A

Q: Does family therapy help bipolar disorder? A: Yes, added to medication. In the primary randomised trial, family-focused therapy reduced relapses and lengthened time to relapse (hazard ratio 0.38, 95% CI 0.20–0.75) and improved medication adherence over two years.¹ The guideline recommends offering a family intervention to people in close contact with their family.⁷

Q: What can I actually do that helps? A: Three things with evidence behind them: give a corroborative history at assessment;⁴ help build and use a written early-warning-sign and relapse-prevention plan;⁵ ⁸ and support ordinary physical health care, which is where most of the excess mortality sits.²⁰

Q: They've stopped their medication. What do I do? A: Find out which part is unbearable — side effects account for the large majority of lithium discontinuations — and get that to the prescriber.¹⁷ Separately, tell the prescriber that a stop is happening or has happened, because rapid discontinuation carries a specific early-recurrence risk.¹⁸ What does not work is a fight about compliance.

Q: How do I tell an ordinary bad week from the start of an episode? A: That is exactly what an early-warning-sign list, written by the person while well, is for — and why it should name specific, observable things rather than moods.⁸ Sleep is usually the most reliable single indicator.

Q: Is it my fault when they relapse? A: No. Recurrence is common even under good treatment: of 858 people who recovered in the largest effectiveness study, 48.5 percent had a recurrence within two years, and the strongest predictor was residual symptoms at recovery, not anything a family did.¹³

Q: Should I take away the credit cards during a manic episode? A: That belongs in the plan, agreed in advance with the person while well, which is what turns it from a confiscation into an arrangement. The guideline names excessive spending and financial exploitation among the risks to plan for.⁹

Q: What if it's my child? A: The trials in young people all involved the family, and the diagnostic question in children has its own answer. Can a child have bipolar disorder? →

Ready to find support for yourself as well as for them? Filter therapists by approach, schedule and payment route → · The full bipolar map → · Caregivers →

In crisis? Call or text 988 — free, 24/7.

Sources

  1. Miklowitz DJ, George EL, Richards JA, Simoneau TL, Suddath RL, "A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder," Archives of General Psychiatry 60(9), 2003, 904–912 — 101 patients, 21 sessions over nine months; "Patients undergoing FFT had fewer relapses (11/31, 35%) and longer survival intervals… (hazard ratio, 0.38; 95% confidence interval, 0.20-0.75; P = .003)"; "greater reductions in mood disorder symptoms and better medication adherence during the 2 years" — doi.org.
  2. Miklowitz DJ, Efthimiou O, Furukawa TA, et al., "Adjunctive psychotherapy for bipolar disorder: a systematic review and component network meta-analysis," JAMA Psychiatry 78(2), 2021, 141–150 — 39 trials, 3,863 participants; "Psychoeducation with guided practice of illness management skills in a family or group format was associated with reducing recurrences vs the same strategies in an individual format (OR, 0.12; 95% CI, 0.02-0.94)" — pmc.ncbi.nlm.nih.gov.
  3. Scott J, Graham A, Yung A, Morgan C, Bellivier F, Etain B, "A systematic review and meta-analysis of delayed help-seeking, delayed diagnosis and duration of untreated illness in bipolar disorders," Acta Psychiatrica Scandinavica 146(5), 2022, 389–405 — median delay in diagnosis 6.7 years — europepmc.org.
  4. National Institute for Health and Care Excellence, "Bipolar disorder: assessment and management," clinical guideline CG185, recommendation 1.3.2 — "encourage people to invite a family member or carer to give a corroborative history" — nice.org.uk.
  5. Morriss RK, Faizal MA, Jones AP, Williamson PR, Bolton C, McCarthy JP, "Interventions for helping people recognise early signs of recurrence in bipolar disorder," Cochrane Database of Systematic Reviews 1, 2007, CD004854 — "Time to first recurrence of any type (RE, hazards ratio 0.57, 95% CI 0.39 to 0.82)… favoured the intervention group"; "Mental health services should consider routinely providing EWS interventions to adults with bipolar disorder" — doi.org.
  6. Rea MM, Tompson MC, Miklowitz DJ, Goldstein MJ, Hwang S, Mintz J, "Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial," Journal of Consulting and Clinical Psychology 71(3), 2003, 482–492 — "those in family-focused treatment were less likely to be rehospitalized during the 2-year study period" — doi.org.
  7. National Institute for Health and Care Excellence, clinical guideline CG185, recommendation 1.7.2 — "Offer a family intervention to people with bipolar disorder who are living, or in close contact, with their family" — nice.org.uk.
  8. National Institute for Health and Care Excellence, clinical guideline CG185, recommendation 1.4.1 and recommendation 1.3.7 on crisis planning — the risk management plan covering triggers, early warning signs, an agreed protocol, and contacts, developed "jointly with the person, and their carer if possible" — nice.org.uk.
  9. National Institute for Health and Care Excellence, clinical guideline CG185, recommendation 1.3.5 — the risk assessment areas, including "driving, spending money excessively, financial or sexual exploitation" — nice.org.uk.
  10. Judd LL, Akiskal HS, Schettler PJ, et al., "The long-term natural history of the weekly symptomatic status of bipolar I disorder," Archives of General Psychiatry 59(6), 2002, 530–537 — symptomatic 47.3% of weeks, depressed 31.9% — europepmc.org.
  11. Judd LL, Akiskal HS, Schettler PJ, et al., "A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder," Archives of General Psychiatry 60(3), 2003, 261–269 — symptomatic 53.9% of weeks, depressed 50.3% — europepmc.org.
  12. Judd LL, Akiskal HS, Schettler PJ, et al., "Psychosocial disability in the course of bipolar I and II disorders," Archives of General Psychiatry 62(12), 2005, 1322–1330 — impairment rising with depressive symptom severity; subsyndromal hypomanic symptoms not disabling — doi.org.
  13. Perlis RH, Ostacher MJ, Patel JK, et al., "Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)," American Journal of Psychiatry 163(2), 2006, 217–224 — 48.5% recurrence within two years among those who recovered; residual symptoms at recovery as the strongest predictor — doi.org.
  14. Tohen M, Zarate CA, Hennen J, et al., "The McLean-Harvard First-Episode Mania Study," American Journal of Psychiatry 160(12), 2003, 2099–2107 — 98% syndromal recovery and 43% functional recovery within two years — doi.org.
  15. Semahegn A, Torpey K, Manu A, Assefa N, Tesfaye G, Ankomah A, "Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis," Systematic Reviews 9, 2020, 17 — "psychotropic medication non-adherence for schizophrenia, major depressive disorders, and bipolar disorders were 56%, 50%, and 44%, respectively" — doi.org.
  16. Prajapati AR, Dima A, Mosa G, et al., "Mapping modifiable determinants of medication adherence in bipolar disorder (BD) to the theoretical domains framework (TDF): a systematic review," Psychological Medicine 51(7), 2021, 1082–1098 — 57 studies, 32,894 participants; "Around 40% of people with bipolar disorder (BD) are non-adherent to medication"; the most common determinant domains — doi.org.
  17. Öhlund L, Ott M, Oja S, et al., "Reasons for lithium discontinuation in men and women with bipolar disorder: a retrospective cohort study," BMC Psychiatry 18, 2018, 37 — "Of 873 patients treated with lithium, 54% discontinued lithium… In 62% of episodes, lithium was discontinued due to adverse effects"; the five most common adverse effects — doi.org.
  18. Suppes T, Baldessarini RJ, Faedda GL, Tohen M, "Risk of recurrence following discontinuation of lithium treatment in bipolar disorder," Archives of General Psychiatry 48(12), 1991, 1082–1088 — "More than 50% of new episodes of illness occurred within 10 weeks of stopping" — doi.org.
  19. Hayes JF, Miles J, Walters K, King M, Osborn DP, "A systematic review and meta-analysis of premature mortality in bipolar affective disorder," Acta Psychiatrica Scandinavica 131(6), 2015, 417–425 — all-cause SMR 2.05, suicide SMR 14.44, natural-cause SMR 1.64 — pmc.ncbi.nlm.nih.gov.
  20. Crump C, Sundquist K, Winkleby MA, Sundquist J, "Comorbidities and mortality in bipolar disorder: a Swedish national cohort study," JAMA Psychiatry 70(9), 2013, 931–939 — "Women and men with bipolar disorder died 9.0 and 8.5 years earlier on average than the rest of the population"; the weaker association among those with a prior diagnosis of the physical condition, "suggesting that better provision of primary medical care may effectively reduce premature mortality among persons with bipolar disorder" — doi.org.
  21. Ösby U, Brandt L, Correia N, Ekbom A, Sparén P, "Excess mortality in bipolar and unipolar disorder in Sweden," Archives of General Psychiatry 58(9), 2001, 844–850 — "For bipolar disorder, most excess deaths were from natural causes" — doi.org.
  22. National Alliance on Mental Illness, "NAMI Family-to-Family" — "a free, 8-session educational program for family, significant others and friends of people with mental health conditions" — nami.org; NAMI California affiliate finder — namica.org; Dixon LB, Lucksted A, Medoff DR, et al., "Outcomes of a randomized study of a peer-taught Family-to-Family Education Program for mental illness," Psychiatric Services 62(6), 2011, 591–597 — 318 participants; "FTF participants had significantly greater improvements in problem-focused coping as measured by empowerment and illness knowledge… Subjective illness burden did not differ between groups" — pmc.ncbi.nlm.nih.gov.

Paid for by participating therapists. Inclusion is computed from availability data — never purchased. No ads, no data sold.